Go Pro

Tilray Brands (TLRY) Competitors

Tilray Brands logo
C$6.33 -0.22 (-3.36%)
As of 12:54 PM Eastern

TLRY vs. BHC, MJN, CARA, CRON, and DHT.UN

Should you buy Tilray Brands stock or one of its competitors? Tilray Brands's main competitors and comparable companies include Bausch Health Companies (BHC), Cronos Group (MJN), Cara Operations (CARA), Cronos Group (CRON), and DRI Healthcare Trust (DHT.UN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Tilray Brands compare to Bausch Health Companies?

Tilray Brands (TSE:TLRY) and Bausch Health Companies (TSE:BHC) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, valuation, analyst recommendations, media sentiment and dividends.

Tilray Brands has a beta of 2.949831, meaning that its share price is 195% more volatile than the broader market. Comparatively, Bausch Health Companies has a beta of 0.959729, meaning that its share price is 4% less volatile than the broader market.

Bausch Health Companies has higher revenue and earnings than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A
Bausch Health CompaniesC$10.85B0.31-C$125.65M-C$2.94N/A

In the previous week, Tilray Brands and Tilray Brands both had 2 articles in the media. Bausch Health Companies' average media sentiment score of 0.13 beat Tilray Brands' score of -0.09 indicating that Bausch Health Companies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bausch Health Companies
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

4.6% of Tilray Brands shares are owned by institutional investors. Comparatively, 10.6% of Bausch Health Companies shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Comparatively, 11.3% of Bausch Health Companies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Bausch Health Companies has a net margin of -12.02% compared to Tilray Brands' net margin of -15.22%. Bausch Health Companies' return on equity of 87.57% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-15.22% -8.85% -1.41%
Bausch Health Companies -12.02%87.57%4.16%

Tilray Brands presently has a consensus price target of C$13.30, suggesting a potential upside of 110.11%. Given Tilray Brands' higher possible upside, equities analysts plainly believe Tilray Brands is more favorable than Bausch Health Companies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Bausch Health Companies
0 Sell rating(s)
3 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Bausch Health Companies beats Tilray Brands on 9 of the 13 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Tilray Brands (TSE:TLRY) and Cronos Group (CVE:MJN) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

Cronos Group has lower revenue, but higher earnings than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A
Cronos GroupN/AN/AN/AN/AN/A

Cronos Group has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-15.22% -8.85% -1.41%
Cronos Group N/A N/A N/A

4.6% of Tilray Brands shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

In the previous week, Tilray Brands had 1 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Tilray Brands and 1 mentions for Cronos Group. Cronos Group's average media sentiment score of 0.67 beat Tilray Brands' score of -0.09 indicating that Cronos Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Cronos Group
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands presently has a consensus target price of C$13.30, suggesting a potential upside of 110.11%. Given Tilray Brands' stronger consensus rating and higher probable upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Tilray Brands beats Cronos Group on 6 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cara Operations?

Tilray Brands (TSE:TLRY) and Cara Operations (TSE:CARA) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their profitability, risk, institutional ownership, media sentiment, earnings, valuation, dividends and analyst recommendations.

Cara Operations has lower revenue, but higher earnings than Tilray Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A
Cara OperationsN/AN/AN/AN/AN/A

Cara Operations has a net margin of 0.00% compared to Tilray Brands' net margin of -15.22%. Cara Operations' return on equity of 0.00% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-15.22% -8.85% -1.41%
Cara Operations N/A N/A N/A

In the previous week, Tilray Brands had 2 more articles in the media than Cara Operations. MarketBeat recorded 2 mentions for Tilray Brands and 0 mentions for Cara Operations. Cara Operations' average media sentiment score of 0.00 beat Tilray Brands' score of -0.09 indicating that Cara Operations is being referred to more favorably in the news media.

Company Overall Sentiment
Tilray Brands Neutral
Cara Operations Neutral

4.6% of Tilray Brands shares are held by institutional investors. 0.7% of Tilray Brands shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Tilray Brands currently has a consensus price target of C$13.30, suggesting a potential upside of 110.11%. Given Tilray Brands' stronger consensus rating and higher probable upside, equities research analysts plainly believe Tilray Brands is more favorable than Cara Operations.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
Cara Operations
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Tilray Brands beats Cara Operations on 6 of the 10 factors compared between the two stocks.

How does Tilray Brands compare to Cronos Group?

Cronos Group (TSE:CRON) and Tilray Brands (TSE:TLRY) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Cronos Group has higher earnings, but lower revenue than Tilray Brands. Tilray Brands is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos GroupC$179.09M8.80-C$32.78MC$0.1922.53
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A

Cronos Group presently has a consensus target price of C$4.92, indicating a potential upside of 14.88%. Tilray Brands has a consensus target price of C$13.30, indicating a potential upside of 110.11%. Given Tilray Brands' higher probable upside, analysts plainly believe Tilray Brands is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Cronos Group and Cronos Group both had 2 articles in the media. Cronos Group's average media sentiment score of 0.47 beat Tilray Brands' score of -0.09 indicating that Cronos Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

4.4% of Cronos Group shares are owned by institutional investors. Comparatively, 4.6% of Tilray Brands shares are owned by institutional investors. 46.4% of Cronos Group shares are owned by company insiders. Comparatively, 0.7% of Tilray Brands shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Cronos Group has a net margin of 38.95% compared to Tilray Brands' net margin of -15.22%. Cronos Group's return on equity of 6.46% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group38.95% 6.46% -3.73%
Tilray Brands -15.22%-8.85%-1.41%

Cronos Group has a beta of 1.13355, suggesting that its share price is 13% more volatile than the broader market. Comparatively, Tilray Brands has a beta of 2.949831, suggesting that its share price is 195% more volatile than the broader market.

Summary

Cronos Group beats Tilray Brands on 10 of the 15 factors compared between the two stocks.

How does Tilray Brands compare to DRI Healthcare Trust?

Tilray Brands (TSE:TLRY) and DRI Healthcare Trust (TSE:DHT.UN) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation, analyst recommendations and media sentiment.

Tilray Brands presently has a consensus target price of C$13.30, suggesting a potential upside of 110.11%. DRI Healthcare Trust has a consensus target price of C$25.20, suggesting a potential upside of 38.77%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than DRI Healthcare Trust.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tilray Brands
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00
DRI Healthcare Trust
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
3.20

4.6% of Tilray Brands shares are owned by institutional investors. Comparatively, 0.8% of DRI Healthcare Trust shares are owned by institutional investors. 0.7% of Tilray Brands shares are owned by company insiders. Comparatively, 0.1% of DRI Healthcare Trust shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

DRI Healthcare Trust has lower revenue, but higher earnings than Tilray Brands. DRI Healthcare Trust is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tilray BrandsC$915.45M0.94-C$183.24M-C$1.09N/A
DRI Healthcare TrustC$172.34M5.80C$9.73M-C$0.80N/A

DRI Healthcare Trust has a net margin of 5.02% compared to Tilray Brands' net margin of -15.22%. DRI Healthcare Trust's return on equity of 2.06% beat Tilray Brands' return on equity.

Company Net Margins Return on Equity Return on Assets
Tilray Brands-15.22% -8.85% -1.41%
DRI Healthcare Trust 5.02%2.06%4.22%

In the previous week, DRI Healthcare Trust had 3 more articles in the media than Tilray Brands. MarketBeat recorded 5 mentions for DRI Healthcare Trust and 2 mentions for Tilray Brands. DRI Healthcare Trust's average media sentiment score of 1.12 beat Tilray Brands' score of -0.09 indicating that DRI Healthcare Trust is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tilray Brands
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
DRI Healthcare Trust
4 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tilray Brands has a beta of 2.949831, suggesting that its share price is 195% more volatile than the broader market. Comparatively, DRI Healthcare Trust has a beta of 0.350693, suggesting that its share price is 65% less volatile than the broader market.

Summary

DRI Healthcare Trust beats Tilray Brands on 11 of the 17 factors compared between the two stocks.

Get Tilray Brands News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilray BrandsPharmaceuticals IndustryHealthcare SectorTSE Exchange
Market CapC$862.17MC$11.72BC$6.98BC$12.55B
Dividend YieldN/A2.70%2.58%6.20%
P/E Ratio-5.81781.44269.2730.74
Price / Sales0.94748.15597.319.76
Price / Cash5.9567.4570.5382.29
Price / Book0.4610.7713.074.64
Net Income-C$183.24MC$2.78BC$3.45BC$299.09M
7 Day Performance-0.47%-0.17%0.74%0.92%
1 Month Performance2.93%0.00%1.40%3.90%
1 Year Performance-61.17%161.17%67.03%36.15%

Tilray Brands Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray Brands
1.3283 of 5 stars
C$6.33
-3.4%
C$13.30
+110.1%
-61.9%C$862.17MC$915.45MN/A2,650
BHC
Bausch Health Companies
0.6025 of 5 stars
C$8.80
-3.0%
N/A-10.5%C$3.29BC$10.85BN/A19,900
MJN
Cronos Group
N/AC$12.15
-1.9%
N/A+0.0%C$1.73BN/AN/A7,600
CARA
Cara Operations
N/AN/AN/AN/AC$1.62BN/AN/A80
CRON
Cronos Group
2.9829 of 5 stars
C$3.80
-3.6%
C$4.75
+25.0%
+21.8%C$1.42BC$159.54MN/A450

Related Companies and Tools


This page (TSE:TLRY) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners